Orbimed Advisors LLC Cel Sci Corp Put Options Transaction History

Orbimed Advisors LLC

  • $4.24 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$8.68 - $27.49 $868,000 - $2.75 Million
-100,000 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$12.0 - $27.64 $1.2 Million - $2.76 Million
100,000 New
100,000 $1.52 Million
Q4 2019

Feb 14, 2020
SELL
$6.71 - $9.55 $838,750 - $1.19 Million
-125,000 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$6.0 - $9.6 $750,000 - $1.2 Million
125,000 New
125,000 $1.12 Million

Others Institutions Holding CVM

# of Institutions
71
Shares Held
6M
Call Options Held
27.1K
Put Options Held
150K
View Full List

About CEL SCI CORP

CVM Quotes by TradingView
  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $26.9M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email